The future is here: Ventricular assist devices for the failing heart

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 9, 2009, Pages 1067-1077

  Alba, Ana C ^a   Delgado, Diego H ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bridge to transplant; Clinical experience; Destination therapy; Heart failure; Indication; Myocardial recovery; Survival; Ventricular assist device

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTICOAGULATION; AORTA BALLOON; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEVICE REMOVAL; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; KIDNEY DYSFUNCTION; PUMP DESIGN; REVIEW; SURVIVAL RATE; SURVIVAL TIME;

CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; SURVIVAL RATE;

EID: 70450191280     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.86     Document Type: Review

References (51)

1. Taylor DO, Edwards LB, Aurora P et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth Official Adult Heart Transplant Report - 2008. J. Heart Lung Transplant. 27, 943-956 (2008).
2. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation. Analysis of Organ Procurement and Transplantation Network/U.S. United Network of Organ Sharing Data, 1990 to 2005. J. Am. Coll. Cardiol. 50, 1282-1290 (2007).
3. Delgado DH, Rao V, Ross H, Verma S, Smedira N. Mechanical circulatory assistance: state of art. Circulation 106(16), 2046-2050 (2002). (Pubitemid 35192808)
4. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N. Engl. J. Med. 339, 1522-1533 (1998).
5. Rao V, Oz MC, Edwards NM et al. A new off-pump technique for thoratec right ventricular assist device insertion. Ann. Thorac. Surg. 71, 1719-1720 (2001). (Pubitemid 32452591)
6. McCarthy PM, Smedira NO, Vargo RL et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J. Thorac. Cardiovasc. Surg. 115, 904-912 (1998).
7. Frazier OH, Rose EA, Oz MC et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J. Thorac. Cardiovasc. Surg. 122, 1186-1195 (2001). •• Important study providing strong evidence regarding the use of ventricular assist devices as a bridge to transplantation.
8. Lietz K. Miller LW. Destination therapy: current results and future promise. Thorac. Cardiovasc. Surg. 20, 225-233 (2008).
9. Crow S, John R, Boyle A et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J. Thorac. Cardiovasc. Surg. 137, 208-215 (2009).
10. Morgan JA, John R, Rao V et al. Bridging to transplant with the HeartMate left ventricular assist device: the Columbia Presbyterian 12-year experience. J. Thorac. Cardiovasc. Surg. 127, 1309 (2004). (Pubitemid 38560592)
11. Degenaris F, Portner PM, Robbisns RC, Over PE. The Novacor left ventricular assist system: clinical experience from the Novacor registry. J. Card. Surg. 16(4), 267-271 (2001).
12. Pae WE, Connell JM, Adelowo A et al. Clinical Utility Baseline Study (CUBS) Group. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J. Heart Lung Transplant. 26, 219-229 (2007).
13. Miller LW, Pagani FD, Rusell SD et al. Use of continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 357, 885-896 (2007).
14. John R, Kamdar F, Liao K et al. Improved survival and decreasing incidence of adverse events using the HeartMate II left ventricular assist device as a bridge-to-transplant. Ann. Thorac. Surg. 86, 1227-1234 (2008). • Important study showing how outcomes are improving with the use of the newer generation devices.
15. John R, Kamdar F, Liao K et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J. Thorac. Cardiovasc. Surg. 136, 1318-1323 (2008).
16. Goldstein DJ. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device® as a bridge to transplantation. Circulation 108(II), 272-277 (2003).
17. Siegenthaler MP, Martin J, Pernice K et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur. J. Cardiovasc. Surg. 23, 748-755 (2003).
18. Frazier OH, Myers TJ, Westaby S et al. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann. Surg. 237, 631-637 (2003).
19. Siegenthaler MP, Westaby S, Frazier OH et al. Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur. Heart J. 26, 1031-1038 (2005). (Pubitemid 40695034)
20. Westaby S, Frazier OH, Banning A. Six years of continuous mechanical circulatory support. N. Engl. J. Med. 355, 325-327 (2006). (Pubitemid 44079365)
21. Siegenthaler MP, Frazier OH, Beyersdorf F et al. Mechanical reliability of the Jarvik 2000 heart. Ann. Thorac. Surg. 81, 1752-1759 (2006).
22. Pagani FD. Continuous-flow rotary left ventricular assist devices with "3rd generation" design. Thorac. Cardiovasc. Surg. 20, 255-263 (2008). • Good review on third-generation devices.
23. Esmore DS, Kaye D, Negri JC et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J. Heart Lung Transplant. 27, 579-588 (2008).
24. Esmore DS, Kaye D, Negri JC et al. Cumulative support outcomes of 3 clinical trials for the VentrAssist LVAD. J. Heart Lung Transplant. 26(2S), 103 (2007).
25. Nojiri C, Fey O, Jaschke F et al. DuraHeart 3rd generation Mag-Lev Centrifugal Left Ventricular Assist System: European experience. J. Heart Lung Transplant. 27, S245 (2008).
26. Wieselthaler GM, Strueber M, O'Driscoll GA et al. Experience with the novel HeartWare HVAD with hydromagnetically levitated rotor in a multi-institutional trial. J. Heart Lung Transplant. 27, S245 (2008).
27. Wood C, Maiorana A, Larbalestier R, Lovett M, Green G, O'Driscoll G. First successful bridge to myocardial recovery with a HeartWare HVAD. J. Heart Lung Transplant. 27, 695-697 (2008). (Pubitemid 351707625)
28. Snyder TA, Tsukui H, Kihara S et al. Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: Coating comparison and platelet activation. J. Biomed. Mater. Res. 81A, 85-92 (2007). (Pubitemid 46435456)
29. Yamazaki K, Saito S, Nisbinaka T et al. Japanese clinical trial results of an implantable centrifugal blood pump "EVAHEART". J. Heart Lung Transplant. 27, S246 (2008).
30. Kirklin JK, Naftel DC, Stevenson LW et al. INTERMACS Database for durable devices for circulatory support: First annual report. J. Heart Lung Transplant. 27, 1065-1072 (2008). •• Largest multicenter report in patients undergoing mechanical circulatory support therapy.
31. Deng MC, Weyand M, Hammel D et al. Selection and management of ventricular assist device patients: the muenster experience. J. Heart Lung Transplant. 19, S77-S82 (2000). (Pubitemid 30658219)
32. Alba AC, Ivanov J, Rao V, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes post-mechanical assist device implantation. The Can. J. Cardiol. 24(E), 202 (2008).
33. Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of Continuous Outpatient Support with Inotropes (COSI) in patients with refractory endstage heart failure. J. Cardiac. Failure 9(3), 180-187 (2003). •• Interesting study showing mortality rate and survival in heart failure patients treated with intravenous inotropes. (Pubitemid 36734314)
34. Cleveland JC, Grover FL, Fullerton DA et al. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival. J. Thorac. Cardiovasc. Surg. 136, 774-777 (2008).
35. Kay J, Teuteberg JJ, Simon MA et al. Ventricular assist device adverse events affect not only VAD survival but subsequent survival after cardiac transplantation. J. Heart Lung Transplant. 27(2S), 169 (2008).
36. Patlolla V, Patten RD, DeNofrio D, Konstam MA, Krishnamani R. The effect of ventricular assist devices on post-transplant mortality. An analysis of the United Network for Organ Sharing Thoracic Registry. J. Am. Coll. Cardiol. 53, 264-271 (2009). •• Well designed study that compared post-transplant survival in patients who were bridged with different types of ventricular assist devices versus high-status heart transplant candidates.
37. Rose EA, Gelijns AC, Moskowitz AJ et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N. Engl. J. Med. 345, 1435-1443 (2001). •• Landmark study showing the benefit of ventricular assist devices therapy as destination therapy in nontrans plant candidates.
38. Rogers JG, Butler J, Lansman SL et al; INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J. Am. Coll. Cardiol. 50, 741-747 (2007). (Pubitemid 47239315)
39. Lietz K, Long JW, Kfoury AG et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116, 497-505 (2007). (Pubitemid 47450258)
40. Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circualtion 112, E111-E115 (2005).
41. Drakos SG, Kanakakis JV, Nanas S et al. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. J. Cardiovasc. Pharmacol. 53(2), 157-161 (2009).
42. Kittleson M, Hurwitz S, Shah MR et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J. Am. Coll. Cardiol. 41, 2029-2035 (2003). (Pubitemid 36677127)
43. Kirklin JK, Fraizer OH. Developmental history of the mechanical circulatory support. In: ISHLT monograph series: Mechanical Circulatory Support (Volume 1). Kirklin JK, Fraizer OH (Eds). Elsevier, NY, USA, 1-8 (2006).
44. Klotz S, Danser AH, Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog. Biophys. Mol. Biol. 97, 479-496 (2008). •• Interesting review explaining molecular, cellular and echocardiographic changes involved in the process of reverse remodeling.
45. Maybaum S, Mancini D, Xydas S et al. Cardiac improvement during mechanical circulatory support. A prospective multicenter study of the LVAD Working Group. Circulation 115, 2497-2505 (2007). (Pubitemid 46763223)
46. Simon MA, Kormos RL, Murali S et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics and outcomes. Circulation 112(Suppl. I), I32-I36 (2005). (Pubitemid 41266650)
47. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur. Heart J. 22(7), 534-540 (2001). •• First article showing and describing the concept of maximizing the potential of native heart recovery with the combination of mechanical unloading and pharmacologic therapy.
48. George I, Xydas S, Mancini DM et al. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J. Heart Lung Transplant. 25, 1084-1090 (2006). (Pubitemid 44311534)
49. Dandel M, Weng Y, Siniawski H, Potapov E, Lehmkuhl HB, Hetzer R. Longterm results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112(Suppl. 9), I37-I45 (2005). •• Very interesting paper summarizing the bridge-to-recovery long-term outcomes of a large series of nonischemic cardiomyopathy patients. (Pubitemid 41266651)
50. Sun BC, Firstenberg MS, Louis LB et al. Placement of long-term implantable ventricular assist devices without the use of cardiopulmonary bypass. J. Heart Lung Transplant. 27(7), 718-721 (2008).
51. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado D. Predictors of acute renal dysfunction after ventricular assist device placement. J. Heart Lung Transplant. 28(2), S79-S79 (2009).